Please login to the form below

Not currently logged in
Email:
Password:

Aurinia Pharmaceuticals

This page shows the latest Aurinia Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Lupus trial hailed as a success despite patient deaths

Lupus trial hailed as a success despite patient deaths

Phase IIb trial of Aurinia Pharmaceuticals’ voclosporin met its objective. A medical charity representing patients with lupus erythematosus has welcomed the results of a study showing the efficacy of a new ... The phase IIb trial of Aurinia

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Bayer veteran joins Aurinia as CEO Bayer veteran joins Aurinia as CEO

    Stephen Zaruby spent 20 years at German pharma company. Aurinia Pharmaceuticals has appointed Stepen Zaruby as president and CEO. ... Aurinia is well positioned to bring voclosporin forward as an important new treatment for lupus nephritis,” he said.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....